Meadow Creek Investment Management’s Edwards Lifesciences EW Stock Holding History

Meadow Creek Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.47M	Buy	20,112 +2,640	+15%	+$185K	0.03%	390
2019 Q2	$1.08M	Buy	17,472 +2,640	+18%	+$160K	0.02%	469
2019 Q1	$946K	Buy	14,832 +1,920	+15%	+$110K	0.02%	481
2018 Q4	$659K	Buy	12,912 +1,344	+12%	+$68K	0.02%	537
2018 Q3	$671K	Sell	11,568 -144	-1%	-$7.04K	0.01%	607
2018 Q2	$568K	Buy	11,712 +672	+6%	+$31.4K	0.01%	602
2018 Q1	$513K	Sell	11,040 -960	-8%	-$41.7K	0.01%	638
2017 Q4	$451K	Buy	12,000 +2,784	+30%	+$102K	0.01%	693
2017 Q3	$336K	Sell	9,216 -4,944	-35%	-$189K	0.01%	736
2017 Q2	$558K	Sell	14,160 -7,536	-35%	-$275K	0.01%	563
2017 Q1	$680K	Sell	21,696 -43,824	-67%	-$1.37M	0.02%	467
2016 Q4	$2.05M	Buy	+65,520	New	+$2.12M	0.05%	269

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Meadow Creek Investment Management's EW Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Edwards Lifesciences (EW) stake by 15% in Q3 2019, buying an estimated $185K and bringing the position to 20,112 shares worth $1.47M. The position accounts for 0.03% of the portfolio, ranked #390.

Meadow Creek Investment Management first reported a position in EW in Q4 2016 and has held it in 12 quarters since. The position peaked at $2.05M in Q4 2016. 965 funds tracked by Wall St. Rank hold EW as of Q3 2019.

Meadow Creek Investment Management held 20,112 shares of Edwards Lifesciences worth $1.47M as of Q3 2019.
Meadow Creek Investment Management bought 2,640 Edwards Lifesciences shares in Q3 2019, an estimated $185K.
Edwards Lifesciences made up 0.03% of Meadow Creek Investment Management's portfolio in Q3 2019, its #390 holding.
Meadow Creek Investment Management first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's Edwards Lifesciences position peaked at $2.05M in Q4 2016.
965 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.